GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Marketable Securities

Kangmei Pharmaceutical Co (SHSE:600518) Marketable Securities : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Kangmei Pharmaceutical Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥0 Mil.

Kangmei Pharmaceutical Co's annual Marketable Securities declined from Dec. 2021 (¥1 Mil) to Dec. 2022 (¥0 Mil) and declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).


Kangmei Pharmaceutical Co Marketable Securities Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Marketable Securities Chart

Kangmei Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.52 0.12 0.08

Kangmei Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.10 0.09 0.08 0.08

Kangmei Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Kangmei Pharmaceutical Co  (SHSE:600518) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Kangmei Pharmaceutical Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.
Executives
Xu Dong Jin Director
Li Jian Hua senior management
Qiu Xi Wei Director
Wang Min senior management
Peng Qin senior management
Ma Xing Tian Director
Lin Guo Xiong senior management
Zhuang Yi Qing senior management
Wen Shao Sheng Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines